Adma Biologics (ADMA) Prepaid Assets (2011 - 2025)

Adma Biologics' Prepaid Assets history runs 14 years deep, the most recent figure standing at $7.5 million for Q4 2025.

• Quarterly Prepaid Assets fell 7.11% year-over-year to $7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.5 million (down 7.11% YoY) and the FY2025 annual result came in at $7.5 million, down 7.11% from the prior year.
• Prepaid Assets was $7.5 million for Q4 2025 at Adma Biologics, up from $6.9 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $9.5 million in Q3 2024 and bottomed at $3.7 million in Q1 2024.
• A 5-year average of $6.1 million and a median of $5.5 million in 2022 frame the typical range for Prepaid Assets.
• Peak annual rise in Prepaid Assets reached 129.59% in 2025, while the deepest fall reached 27.4% in 2025.
• Adma Biologics' Prepaid Assets stood at $4.3 million in 2021, then rose by 17.42% to $5.1 million in 2022, then grew by 4.69% to $5.3 million in 2023, then surged by 50.52% to $8.0 million in 2024, then slipped by 7.11% to $7.5 million in 2025.
• Business Quant data shows ADMA's Prepaid Assets at $7.5 million in Q4 2025, $6.9 million in Q3 2025, and $8.1 million in Q2 2025.